Subjects (n) | Age | ||||
Dataset | Group | HABs | MABs | HABs | MABs |
Sandiego, 2015 | Lipopolysaccharide | 3 | 5 | 28.0 ± 6.0 (22.7–34.5) | 23.6 ± 5.1 (19.1–31.1) |
Hillmer, 2017 | AUD | ||||
Controls | 8 | 7 | 37.4 ± 9.0 (26.3–48.4) | 32.8 ± 14.6 (19.1–55.6) | |
Patients | 7 | 7 | 40.9 ± 7.9 (31.6–55.2) | 37.9 ± 10.4 (26.9–51.0) | |
Collste, 2017 | FEP | ||||
Controls | 9 | 7 | 27.8 ± 9.3 (22–50) | 25.7 ± 8.2 (20–43) | |
Patients | 6 | 10 | 29.8 ± 8.2 (20–40) | 27.7 ± 8.8 (19–47) | |
Varnäs, 2019 | PD | ||||
Controls | 8 | 8 | 64.9 ± 4.9 (57.8–71.5) | 62.1 ± 5.3 (56.1–72.0) | |
Patients | 8 | 8 | 63.6 ± 4.3 (57.1–69.1) | 63.4 ± 6.4 (55.2–73.2) |
HAB = high-affinity binder; MAB = mixed-affinity binder.
Age is given as mean ± SD, followed by range in parentheses.